Sinopharm: all 95 studies

Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal AntibodyNot yet recruitingNCT07445815Phase 2
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.RecruitingNCT07377175Phase 1
• Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term InfantsNot yet recruitingNCT07363837Phase 1/2
• the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L VaccinesNot yet recruitingNCT07338851
• Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and AboveNot yet recruitingNCT07327398Phase 2
• A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and AboveRecruitingNCT07302256Phase 1
• Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the CongoNot yet recruitingNCT07253675Phase 2
• A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.RecruitingNCT07205198Phase 1
• Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody InjectionEnrolling by invitationNCT07149454Phase 1
• A Clinical Trial of SIBP-A16 Injection in Healthy AdultsRecruitingNCT07106918Early Phase 1
• A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor PatientsRecruitingNCT06990464Phase 1
• A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor PatientsRecruitingNCT06985368Phase 1
• A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy IndividualsRecruitingNCT06932523Phase 1/2
• A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live VaccineRecruitingNCT06771479Phase 1
• A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients.RecruitingNCT06512116Phase 1
• A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.RecruitingNCT06298071Phase 1
• A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.RecruitingNCT06298058Phase 1
• Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell CarcinomaRecruitingNCT06194656Phase 2
• A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 YearsRecruitingNCT05262010Phase 3
• Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule BridgingActive, not recruitingNCT06632912Phase 3
• Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 MonthsCompletedNCT06399003Phase 3
• A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.CompletedNCT06342349Phase 1
• Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)CompletedNCT05916326Phase 3
• A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of AgeActive, not recruitingNCT05839301Phase 3
• A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella VaccineActive, not recruitingNCT05669625Phase 3
• A Clinical Trial of PEGIFNα1b in Chinese Healthy AdultsCompletedNCT05639803Phase 1
• Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical TrialStatus unknownNCT05599516Phase 3
• Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLLStatus unknownNCT05557903Phase 1
• A Study Exploring Efficacy of Peginterferon in Patients With Herpes ZosterCompletedNCT05492591Phase 2
• Clinical Study of F61 Injection in Healthy Chinese SubjectsStatus unknownNCT05483504Phase 1
• Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis PopulationStatus unknownNCT05480436Phase 4
• Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies VaccineStatus unknownNCT05453487Phase 4
• Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and AboveCompletedNCT05408312Phase 1
• To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 YearsStatus unknownNCT05389137Phase 4
• Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and AboveActive, not recruitingNCT05382871Phase 3
• A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19Status unknownNCT05381519Phase 2
• Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and AboveActive, not recruitingNCT05374954Phase 3
• A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and AboveActive, not recruitingNCT05365724Phase 1/2
• A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung CancerCompletedNCT05318443Phase 3
• A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic HyperuricemiaCompletedNCT05302388Phase 1
• A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)Status unknownNCT05293548Phase 2
• A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.CompletedNCT05203601Phase 1
• Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 PatientsStatus unknownNCT05173441Phase 2
• Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, LiveCompletedNCT05161845Phase 4
• Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years OldCompletedNCT05158777Phase 3
• Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 YearsCompletedNCT05138705Phase 4
• Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV InfectedStatus unknownNCT05105295Phase 4
• Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or DiabetesStatus unknownNCT05104437Phase 4
• Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or DiabetesStatus unknownNCT05104333Phase 4
• Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPDStatus unknownNCT05104216Phase 4
• A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, AdsorbedActive, not recruitingNCT05091619Phase 3
• Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4Status unknownNCT05079152Phase 4
• Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPDStatus unknownNCT05075083Phase 4
• Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV InfectedStatus unknownNCT05075070Phase 4
• Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPDStatus unknownNCT05075057Phase 4
• Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV InfectedStatus unknownNCT05075044Phase 4
• Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and AboveStatus unknownNCT05069129Phase 1/2
• Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Wuhan) in Patients With Hypertension and/or DiabetesStatus unknownNCT05065892Phase 4
• Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or DiabetesCompletedNCT05065879Phase 4
• Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and AboveStatus unknownNCT05033847Phase 2
• Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)Status unknownNCT04941261Phase 2
• Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and AboveCompletedNCT04917523Phase 3
• A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19CompletedNCT04869592Phase 1/2
• A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), InactivatedActive, not recruitingNCT04863638Phase 4
• Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4CompletedNCT04790851Phase 4
• A Clinical Trial to Evaluate the Immunogenicity and Safety of PPV23 Vaccine Revaccinations in the ElderlyCompletedNCT04701788Phase 4
• A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years OldCompletedNCT04700618Phase 4
• Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMRStatus unknownNCT04638985Phase 4
• Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepAStatus unknownNCT04636827Phase 4
• Evaluation of the Safety and Immunogenicity of Hepatitis A VaccineStatus unknownNCT04612634Phase 4
• Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4CompletedNCT04559204Phase 4
• A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and AboveCompletedNCT04510207Phase 3
• Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)CompletedNCT04436133Phase 2
• Clinical Trial of Quadrivalent Influenza Virus Split VaccineCompletedNCT04363359Phase 2
• A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCLCompletedNCT04361279Phase 3
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent VaccineCompletedNCT04188691Phase 1
• A Study Comparing SIBP-04 and Bevacizumab in Healthy Male SubjectsCompletedNCT04135898Phase 1
• Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza VaccineCompletedNCT04091880Phase 4
• A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 YearsCompletedNCT04083196Phase 1
• A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 YearsCompletedNCT04072497Phase 1/2
• Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaPCompletedNCT04054882Phase 4
• To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPVCompletedNCT04054492Phase 4
• Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaPStatus unknownNCT04053010Phase 4
• Immunogenicity and Safety of Sabin-IPV Replacement VaccinationCompletedNCT04051736Phase 4
• A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast CancerCompletedNCT03989037Phase 3
• A Study of An Adjuvanted Inactivated H7N9 Influenza VaccineCompletedNCT03755427Phase 2
• A Clinical Trial of A Quadrivalent Influenza VaccineCompletedNCT03744104Phase 3
• A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza VaccineCompletedNCT03369808Phase 1/2
• Comparative Immunogenicity Study of Two Hepatitis A VaccinesStatus unknownNCT03231605Phase 4
• A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)Status unknownNCT02786407Phase 3
• A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate VaccineStatus unknownNCT02481232Phase 1
• A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic MigraineStatus unknownNCT02291380Phase 3
• A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb SpasticityCompletedNCT02280083Phase 3
• Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in InfantsCompletedNCT01494740Phase 2
• The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 VaccineCompletedNCT01336166Phase 2

← Sinopharm overview and focus areas